Yan Leyfman, MD @YLeyfman Twitter profile

Pinned Tweet

Yan Leyfman, MD

4 years

Thank you to @i24News for highlighting our latest #COVID__19 work and my journey as a Chernobyl survivor. #COVID19

Exclusive i24 News Interview with Yan Leyfman about his COVID-19...

i24 News had an exclusive interview with Yan Leyfman about his journey as a survivor of Chernobyl to his current role as Director of the Immunology Group of ...

www.youtube.com

10

20

91

Last Seen Profiles

@bannapafe5

@michelle__chiu

@LetsDefendIO

@Jumana_School

@aditishekar

@ElysiaRoca90007

@ACheeryWave

@PeanutCXN

@TheMVPCamps

@PriSki_A

@onlyjohnnyd

@stw_pdg

@Ufficiale1st

@csp_uchile

@iyan74464303

@EliteNetflix

@LollyBB543

@xrp_cc

@Reply_Totem

@FilmmakerJulie

@hipipo

@BigBodyBands_

@SusanMitchell_

@KiltimaghGAA

@raki_kr_

@anthonyjperry55

@snpraises

@mogzy8

@stw_pdg

@XiangangHuang

@OhioStateSB

@Theorossi

@jpramzyfotos

@minijeffrey

@PabloPe82803746

@TheTayMack

Yan Leyfman, MD

@YLeyfman

3 years

Important study from Global Oncology Leader Dr. @GlopesMd demonstrating in a cohort of 742 patients with #cancer & #covid19 , patients with active disease, #metastasis or progressive cancer exhibited higher #mortality & had lower #SES .

8

37

183

Yan Leyfman, MD

@YLeyfman

3 years

I am extremely honored for this recognition. As a Chernobyl & son of a cancer survivor, I have strived to use my knowledge to contribute to research innovation that can improve patient care. I am very grateful to my mentors who have invested in my growth & career success.

13

8

93

Yan Leyfman, MD

@YLeyfman

4 years

@JoeBiden Having a stutter myself, thank you for bringing awareness to those with disabilities and making it known we are not inferior. One's disabilities should not define them-- a person should be defined by their character, warmth, knowledge, empathy, and leadership.

1

10

64

Yan Leyfman, MD

@YLeyfman

11 months

🙏 Thank you Dr. Park for your guidance, support & mentorship. Thank you for helping to unearth my potential. I am humbled by this honor. 🎉 Looking forward to continuing to make all those who believe in me proud. #Thankful #MentorshipMatters #reachforthestars 🌟

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

11 months

🎉 Congratulations Dr. Yan Leyfman @YLeyfman for being selected a rising star and emerging leader under age 40 for his research in cancer care, COVID 19, and global medical education. We are all very proud of you. @PatrickHwuMD @Dr_R_Kurzrock @drdonsdizon @weldeiry

8

10

62

12

4

73

Yan Leyfman, MD

@YLeyfman

3 years

Honored to be presenting at the 2021 @ASCO Annual Meeting later this week. Our abstract illustrates one of the first #mechanistic interplays between #cancer & #COVID19 supporting by clinical data with a promising #therapeutic intervention. Abstract link:

6

7

54

Yan Leyfman, MD

@YLeyfman

2 years

Infographic from British Society for Immunology showing how how variants can evade #immunity and why booster doses are safe and effective at enhancing the #immune response.

3

28

52

Yan Leyfman, MD

@YLeyfman

11 months

Congratulations to Dr. Rezvani of @MDAndersonNews ! @ASH_hematology could not have selected a more deserving individual.

3

7

51

Yan Leyfman, MD

@YLeyfman

3 years

Honored to be recognized by @sloan_kettering . I will forever be grateful for the great #mentorship & strong foundation in #immunology , #immunotherapy , #CARTcell therapy & #oncology that it provided me.

MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

www.mskcc.org

9

4

46

Yan Leyfman, MD

@YLeyfman

1 year

Honored to be recognized amongst this cohort of elite individuals. Thank you Phacilitate.

8

3

49

Yan Leyfman, MD

@YLeyfman

2 years

January 20 @ 1:30 PM CT! Honored to have been selected by ASTCT to moderate this important session in the CAR T Cell Webinar Series where we will discuss the present & future landscape of cell therapy with our elite panel of Global Leaders— Drs. Barton, Caligiuri & Smith.

1

8

47

Yan Leyfman, MD

@YLeyfman

2 years

Thank you @ConquerCancerFd for highlighting my journey from a Chernobyl survivor to a physician & researcher in oncology. Tragedy has a way of positively shaping one's outlook on life and mission. Thank you for all you do to support the anti-cancer therapies of tomorrow.

Conquer Cancer, the ASCO Foundation

@ConquerCancerFd

2 years

With all the news about #Zaporizhzhya NPP, we thought it was time to check in with someone who knows firsthand how devastating #nuclear radiation can be. Hear from @YLeyfman of @IcahnMountSinai on how his #Chernobyl experience shaped his approach to #cancerresearch .

1

4

19

4

6

46

Yan Leyfman, MD

@YLeyfman

7 months

Honored to be recognized as a 2023 Binaytara Foundation Travel Award Recipient! Appreciate the opportunity to showcase our research at the prestigious 2023 Precision Oncology Summit. It was a pleasure meeting Dr. Shah & I leave inspired by his impactful global oncology work.🧬🎯

5

4

42

Yan Leyfman, MD

@YLeyfman

7 months

Humbled by this recognition from the Nassau County Medical ⚕️ Society. Thank you for highlighting my background, achievements and passions. Thrilled to be part of this dynamic medical 🩺 community that always supports its members. #Gratitude #NassauCountyMedSociety 🌟👩‍⚕️

Nassau County Medical Society

@MedicalNassau

7 months

In an effort to showcase our members and celebrate their accomplishments, we interview a nominated member of the Nassau County Medical Society each month. Please watch the video to learn more about our October 2023 Member of the Month, Yan Leyfman, MD, a Chernobyl survivor,…

2

0

3

5

3

40

Yan Leyfman, MD

@YLeyfman

11 months

Researchers from England develop antibiotic-laden cells as the next frontier to produce precision antibiotics, enhancing efficacy and decreasing resistance. Future is #celltherapy !

Scientists create synthetic blood cells that can be used to kill cancer and superbugs

Scientists have cracked the longstanding problem of how to create a 'skeleton' that can hold artificial cells together and keep them from rupturing

inews.co.uk

1

10

40

Yan Leyfman, MD

@YLeyfman

11 months

Saturday, July 1 @ 4 PM EST on @MedNewsWeek ! We are excited to be hosting Global Leader & Keynote Speaker, Dr. Muzaffar Qazilbash– Director, Myeloma Transplantation and Cellular Therapy at MD Anderson Cancer Center– as he discusses the latest in multiple myeloma therapeutics.

1

8

37

Yan Leyfman, MD

@YLeyfman

9 months

Had a great time 🤝 with Dr. Burris of Sarah Cannon at the 2023 ASCO BT Meeting after his captivating presentation. Grateful for his visit to my posters & his interest in our work. Thank you for investing in the success of the next generation! 🙌🔬 #OncologyConference

1

6

38

Yan Leyfman, MD

@YLeyfman

3 years

Honored to have been selected to present at the 2021 @ASCO Trainee Research Symposium discussing one of the first #mechanistic interplays between #cancer & #COVID19 supporting by clinical data with a promising #therapeutic intervention.

3

5

38

Yan Leyfman, MD

@YLeyfman

11 months

Honored to represent @MedNewsWeek and showcase the one year success of our global education platform at the 2023 @asco meeting.

5

10

36

Yan Leyfman, MD

@YLeyfman

3 years

Study found that >40% of #lymphoma patients did not exhibit adequate respond to #mRNA #vaccines . For patients on anti-CD20 mAb therapy, no patient who who had received treatment within 6 months responded well to mRNA vaccination.

Serologic response to mRNA COVID‐19 vaccination in lymphoma patients

The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.

onlinelibrary.wiley.com

1

15

35

Yan Leyfman, MD

@YLeyfman

4 years

@DrMMurphy That is awesome. You can be the pioneer of the next rendition of pet therapy-- chicken therapy.

0

31

Yan Leyfman, MD

@YLeyfman

3 years

Congratulations to @Mesoblast for their promising results at #ASH20 . MSCs have multi-faceted potential in not only combating #COVID19 but also improving mortality in #GVHD . #stemcelltherapy #cellulartherapy #COVID ー19 #COVID #SARSCoV2 @MesoblastNews

1

0

30

Yan Leyfman, MD

@YLeyfman

2 years

TOMORROW! Thursday, January 20 @ 1:30 PM CT Join us for this important session in the @ASTCT CAR T Cell Webinar Series where we will discuss the present & future landscape of cell therapy with our elite panel of Global Leaders— Drs. Barton, Caligiuri & Shah.

2

9

31

Yan Leyfman, MD

@YLeyfman

1 year

Humbled to have my story as a Chernobyl Survivor be featured in Regeline “Gigi” Sabbat's new book, Healing & Growth. Thank you for the opportunity to discuss my background while highlighting the importance of patient advocacy, support, and patient-centered care.

3

32

Yan Leyfman, MD

@YLeyfman

9 months

The best mentor is someone who doesn’t have anything left to prove and will now look out for your interests." Such a powerful phrase that represents the ethos of true mentorship. 🌟 Thank you, Dr. Rajkumar, for sharing your inspiring journey & values.

Vincent Rajkumar

@VincentRK

9 months

My interview with @ASHClinicalNews on how I got into medicine, my career path, and my mentors. May be of help to trainees. #MedTwitter @ASH_hematology @MayoClinic

5

44

199

4

10

31

Yan Leyfman, MD

@YLeyfman

9 months

Grateful to connect with Global Immunotherapy Leader, Dr. Rezvani of MD Anderson, after her enlightening Keynote presentation about the utility of NK CARs in fighting cancer at #ASCOBT2023 . Excited for the ripple effect her clinical trials will bring to enhance oncology care.🌟🔬

3

2

30

Yan Leyfman, MD

@YLeyfman

2 years

Honored to have contributed to this important work discussing the landscape of immunotherapies in sarcomas. I am very grateful to the mentorship that I received from Dr. Sandra D'Angelo and Dr. Breelyn Wilky. It was a pleasure to learn from sarcoma's great luminaries.

2

4

30

Yan Leyfman, MD

@YLeyfman

6 months

Thank you to the Lymphoma, Leukemia & Myeloma Congress for this prestigious recognition. I am deeply grateful to Dr. Park for your invaluable mentorship, and I extend my appreciation to the dedicated @MedNewsWeek team. 🙏🌟 #Gratitude #TeamEffort

MedNewsWeek

@MedNewsWeek

6 months

📣Congratulations to @MedNewsWeek Co-Founder 🌟Dr. Yan Leyfman🌟 on your well-deserved recognition as a 2023 Global Hero in Healthcare by the @llmcongress .👏🌟 #HeroInHealthcare #LeadershipInspired

2

9

8

29

Yan Leyfman, MD

@YLeyfman

9 months

🎉Congratulations to these inspiring Global Leaders! Personally, it was a great honor to meet 🌟Dr. Julie Gralow🌟 of @ASCO and learn about the remarkable work she is leading in advocating for global oncology equity, education, and access.

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023 - OncoDaily

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023 / 100 Influential Women in Oncology, Georgina Long, Headlines, Julie

oncodaily.com

1

8

29

Yan Leyfman, MD

@YLeyfman

2 years

Great presentation about the nuts & bolts of pathology from the field's global leaders from @HemeReports . Thank to the hosts for your time and insight. Learned a lot.

1

6

29

Yan Leyfman, MD

@YLeyfman

1 year

What is the latest in multiple myeloma therapeutics? What is coming down the pipeline? Bispecifics v CAR T cells? The answer to those questions & more in this world-class presentation from Global Expert Dr. Joseph Mikhael ( @jmikhaelmd ) of @IMFmyeloma .

Multiple Myeloma in 2022: Developments, Directions, and Disparities

A video from Joseph Mikhael (as part of MedNews Week), posted on Nov 1, 2022.

www.vumedi.com

1

8

29

Yan Leyfman, MD

@YLeyfman

1 year

Honored to have been invited to give a Keynote Talk at the 2023 International Meet on Cell Science & Molecular Biology to discuss the efficacy of cell therapies to treat severe SARS-COV-2 in cancer patients. Thank you to the organizers for such an engaging meeting.

3

2

28

Yan Leyfman, MD

@YLeyfman

10 months

An inspirational story of taking a negative and turning it into a mission to alter the landscape of cancer care from 🌟 Dr. Urvi Shah ( @UrviShahMD ) of Memorial Sloan Kettering Cancer Center. Thank you for all that you do!

Food as Medicine: Why One Doctor Thinks Diet Could Help Control Cancer

When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should...

www.mskcc.org

1

6

27

Yan Leyfman, MD

@YLeyfman

1 year

Honored for the opportunity to present our research at the 2023 American Society of Hematology (ASH) Immunotherapy Summit. Thank you to the great mentors & to the dedicated team that contributed to this project.

2

4

27

Yan Leyfman, MD

@YLeyfman

1 year

Happy International Women's Day! We at @MedNewsWeek want to take a moment to acknowledge and celebrate the hard work, dedication, and contributions to medicine of our Keynote Speakers. We are grateful for the opportunity to learn from you. Thank you for all you do!

2

7

26

Yan Leyfman, MD

@YLeyfman

3 years

New strategy to control #CARTcells uses ultrasound to turn them on & off directly in vivo.

Control of the activity of CAR-T cells within tumours via focused ultrasound

Nature Biomedical Engineering - The activity of engineered T cells within tumours can be controlled via the heat generated by pulses of focused ultrasound by modifying the cells to express a...

www.nature.com

1

2

25

Yan Leyfman, MD

@YLeyfman

3 years

Honored to have been selected as a Featured Speaker to present our latest work on Cancer & COVID-19 at the 2021 Goldwater Scholar Symposium.

4

1

25

Yan Leyfman, MD

@YLeyfman

10 months

Honored to have been featured on the Dr. Hwu #FridayFollow short list. Thank you so much for the support. Your inspirational leadership spreads far above Florida & represents a strong dedication to supporting & investing in the next generation of oncologists & HCP. #inspired

Dr. Patrick Hwu

@PatrickHwuMD

10 months

Dr. Yan Leyfman is a clinical researcher and internal medicine resident at Icahn School of Medicine at Mount Sinai. He and his family’s proximity to the 1989 Chernobyl nuclear disaster and the resulting health concerns propelled him to pursue a career in medicine. Go give him a…

1

7

55

1

3

26

Yan Leyfman, MD

@YLeyfman

11 months

Congratulations to Dr. Abdel-Wahab! Thank you for your many vital contributions to the field of hem-onc. Great to see you being recognized by @ASH_hematology .

4

5

26

Yan Leyfman, MD

@YLeyfman

4 years

@DrMeganConroy

1

6

22

Yan Leyfman, MD

@YLeyfman

7 months

🌟 Congratulations Dr. Gralow! Your pioneering leadership in oncology has left an indelible mark on global healthcare. You're a true role model for us all. Thank you for your incredible contributions! 👏👩‍⚕️🌎 #OncologyLeader #Inspiration #HealthcareHero @jrgralow @ASCO @ASCOPres

BioAscend

@BioAscend

7 months

Congratulations @jrgralow #LEAD2023 @WeAreWLO Woman Oncologist of the Year! 🏆

3

11

32

1

2

25

Yan Leyfman, MD

@YLeyfman

9 months

Delighted to meet 🌟Dr. Julie Gralow🌟 (ASCO CMO & EVP) & Dina Michels (ASCO COO) in person at #ASCOBT2023 . Enjoyed discussing ASCO’s global initiatives & passion for nurturing the field’s future leaders. Kudos 👏 for Dr. Gralow's tremendous leadership in ASCO's 🎉 triumphs.

1

6

25

Yan Leyfman, MD

@YLeyfman

11 months

Insightful 2023 @asco plenary session from oncology leader Dr. LaCasce from @DanaFarber . @DrLaCasce

2

3

24

Yan Leyfman, MD

@YLeyfman

1 year

Monday, April 3 @ 7:30 PM EST on @MedNewsWeek ! We are excited to be hosting Global Oncology Leader & Keynote Speaker, Dr. Harpreet Singh– Director of Division of Oncology at US FDA– as she discusses clinical trial innovations. Hope to see you there! @harpreet_md @US_FDA

2

8

24

Yan Leyfman, MD

@YLeyfman

6 months

I'm honored to have successfully completed SITC's inaugural Peer Review Mentorship Program. Learning from global leaders in the field about the intricacies of manuscript review was truly a pleasure.

6

1

24

Yan Leyfman, MD

@YLeyfman

1 year

Riveting presentation about the mechanisms of CAR T cell therapy to improve efficacy against cancer from Immuno-oncology Global Leader, Dr. Marcela Maus ( @MarcelaMaus ) from Massachusetts General Hospital at the 2023 American Society of Hematology Immunotherapies Summit.

1

6

23

Yan Leyfman, MD

@YLeyfman

2 years

Great overview of CAR T cell therapy from Rising Star Dr. Sham Mailankody at the 2022 Lymphoma Leukemia & Myeloma Congress. #immunotherapeutics

1

2

24

Yan Leyfman, MD

@YLeyfman

2 years

Honored to have had the opportunity to present our research about the science & application of social media as a means to tackle healthcare inequity at the 2022 COSMO Meeting at the 2022 @ASCO Annual Meeting. Thank you to Dr. Don Dizon for the opportunity.

2

5

24

Yan Leyfman, MD

@YLeyfman

11 months

Thank you to @OncData for the opportunity to speak about the success and global impact of @MedNewsWeek . Grateful for the mentorship of Dr. Park and the dedicated team that makes these events a reality along with our partners. Looking forward to continued growth.

i3 Health

@i3health

11 months

In this #ASCO23 interview, @OncData sat down with Yan Leyfman, MD, @YLeyfman , to discuss global #health #education through video and social media. Watch now!

0

5

4

3

8

23

Yan Leyfman, MD

@YLeyfman

1 year

I want to wish those who celebrate a very happy Passover. May this Passover be a time of renewal and new beginnings for you and your loved ones. May you find joy in the traditions of the holiday.

2

23

Yan Leyfman, MD

@YLeyfman

2 years

We are honored to be hosting Precision Oncology Global Leader & 2021 NCI Director Award Recipient, Dr. Razelle Kurzrock, as our next Pioneers in Medicine Keynote Speaker. She is a trendsetter who has reshaped the face of precision medicine. @Dr_R_Kurzrock @MedicalCollege

IJCR Central

@CentralIjcr

2 years

Dr. Kurzrock will be joining us in our sixth Pioneers in Medicine webinar as our first female keynote speaker on March 19. This event will be streamed live on IJCR’s website! 🔗 IJCR’s website livestream link: #MedTwitter #Oncology #Genomics #webinar

2

9

20

1

7

23

Yan Leyfman, MD

@YLeyfman

2 years

Thank you to the Lymphoma, Leukemia & Myeloma Congress for an amazing conference highlighting the latest developments in hematological malignancies from the field's global leaders. It was a pleasure learning from the presenters & meeting some of my oncology role models.

2

8

23

Yan Leyfman, MD

@YLeyfman

3 years

It’s rare to find a silver bullet in #medicine , but Mesenchymal #StemCell therapy comes close. Latest data shows that aside from treating #COVID19 , it reduces risk of #MI , #stroke & #cardiacdeath in #CHF pts. #stemcellrx #celltherapy #coronavirus #COVID19

2

16

Yan Leyfman, MD

@YLeyfman

11 months

Riveting keynote presentation on the efficacy of NK CARs in a standing room presentation from global leader Dr. Rezvani from @MDAndersonNews at the 2023 @asco Meeting.

1

8

21

Yan Leyfman, MD

@YLeyfman

3 years

The power of #stemcells has a plethora of uses-- aside from fighting #Covid_19 & improving #transplant outcomes -- they have efficacy against #heartfailure . Congratulations to @Mesoblast for this promising data. #cellulartherapies #COVID19 #coronavirus #SARS_CoV_2 #pandemic

Mesoblast News

@Mesoblast

3 years

Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure

10

7

65

1

0

19

Yan Leyfman, MD

@YLeyfman

9 months

Thrilled to connect with ASCO President— Dr. Schuchter— at #ASCOBT2023 . Thank you for putting on such a rich meeting with inspiring global innovators! Grateful for discussing MedNews Week & our shared commitment to global education & equity. Your interest in our work means a lot.

1

2

20

Yan Leyfman, MD

@YLeyfman

3 years

In a trial of 222 mechanically ventilated #COVID19 patients with mod/severe #ARDS , #MSC therapy reduced #mortality by 48% at 90 days with improved respiratory function by Day 7. When combined with #dexamethasone , 90-day mortality was reduced by 77%.

2

4

17

Yan Leyfman, MD

@YLeyfman

6 months

📣 Monday, November 20 @ 4 PM EST on @MedNewsWeek ! 🩺 We are excited to be Shining the Spotlight on the work of Global Innovator & Keynote Speaker, 🌟Dr. Eric Singhi 🌟 of MD Anderson– as he discusses the latest in lung cancer with an emphasis on mentorship, discovery & advocacy

3

11

20

Yan Leyfman, MD

@YLeyfman

8 months

Thank you to 🌟Dr. Tania Jain🌟– Director, Immune Effector Cell Therapy at Johns Hopkins Hospital– for your riveting Keynote presentation on @MedNewsWeek . It was a pleasure learning from you. We also want to thank our 62,705 attendees across all of our platforms.

Yan Leyfman, MD

@YLeyfman

10 months

📣Saturday, August 5 @ 4 PM EST on @MedNewsWeek !📣 We are excited to be hosting Keynote Speaker, Dr. Tania Jain– Director of Immune Effector Cell Therapy at Johns Hopkins Hospital– as she discusses the latest in CAR T cell 🧫 therapies for hematological 🩸 malignancies.

2

4

10

1

3

20

Yan Leyfman, MD

@YLeyfman

1 year

We here at @MedNewsWeek want to thank our amazing Keynote Speakers for their wonderful presentations. It was a pleasure learning from you. We are very grateful to our 157,559 attendees across all of our platforms.

4

8

20

Yan Leyfman, MD

@YLeyfman

7 months

Honored to be invited amongst 69 researchers nationally to present our latest work on cell therapies against severe SARS-CoV-2 in patients with malignancy at the 2023 Nature Tumour Landscape Conference at MSKCC. Special thanks to Dr. Park for your invaluable mentorship. 🌟🔬

2

3

20

Yan Leyfman, MD

@YLeyfman

10 months

I am honored to represent @MedNewsWeek at @ASCO Breakthrough- a premier global extravaganza for oncology research- and showcase our 3 presentations at this international forum. Thank you Dr. Park for your great mentorship & to the tireless efforts of the dedicated MNW team!

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

10 months

⭐️Congratulations to Dr. Yan Leyfman for being selected as a recipient of the 2023 ASCO Breakthrough Merit Award for high quality scientific research. Looking forward to your presentation at the #ASCOBT23 meeting! @YLeyfman @ASCO 👇

1

7

27

5

7

20

Yan Leyfman, MD

@YLeyfman

2 years

Honored for the opportunity to present our research at the 2022 @ASCO Trainee Symposium about the utility of our platform to connect patients with solid tumors & COVID-19 to clinical trials using social media.

2

3

19

Yan Leyfman, MD

@YLeyfman

2 years

1

2

17

Yan Leyfman, MD

@YLeyfman

2 years

I am humbled. It continues to be a pleasure to review the work of the next generation of research scholars and help them refine their skills. @CentralIjcr is a non-profit with a unique mission to be a launching pad for research careers globally.

IJCR Central

@CentralIjcr

2 years

We are pleased to announce Dr. @YLeyfman as the peer reviewer of the month of #January2022 ! Thank you for all your time and effort! Can you guess who will be the Peer Reviewer of #February2022 ? #MedTwitter #AcademicTwitter #Review

0

2

6

1

18

Yan Leyfman, MD

@YLeyfman

9 months

I am honored to represent @MedNewsWeek at the 2023 American Society of Clinical Oncology (ASCO) Breakthrough Meeting- a premier global extravaganza for oncology research- and showcase our 3 presentations at this international forum today. #ASCOBT23

1

7

19

Yan Leyfman, MD

@YLeyfman

1 year

Thank you Dr. Park for your exceptional mentorship in preparing these abstract presentations. Your expertise, guidance, and support have been invaluable throughout this process. Your mentorship has made a significant impact and I will always be grateful for it.

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️Congratulations to Dr. Yan Leyfman @MountSinaiNYC and the Mount Sinai research team. Dr. Leyfman gave 4 oral presentations at the SITC scientific meeting. Also. an outstanding presentation by Dr. Matt Galsky on immunotherapy in Bladder Cancer. @sitcancer @YLeyfman

2

8

26

6

2

19

Yan Leyfman, MD

@YLeyfman

6 months

📣Monday, November 13 @ 7:30 PM EST on @MedNewsWeek ! We are excited to be hosting Global 🌎 Leader & Keynote Speaker, 🌟Dr. Neha Mehta-Shah🌟– Associate Professor at Siteman Cancer Center at WUSTL– as she discusses the latest in T cell 🧫lymphomas.

1

10

19

Yan Leyfman, MD

@YLeyfman

2 years

To those who celebrate, want to wish you all Shana Tova! May your new year be filled with health, happiness & peace.

2

19

Yan Leyfman, MD

@YLeyfman

8 months

Big thanks to JCO Precision Oncology for the recognition! It's a pleasure to serve as a reviewer for one of the field's leading research journals. Hats off to the outstanding editors for consistently setting a high standard and showcasing innovative work.📚🔬

2

19

Yan Leyfman, MD

@YLeyfman

1 year

Saturday, May 27 @ 4 PM EST on @MedNewsWeek ! We are excited to be hosting Global Leader & Keynote Speaker, Dr. Seth M. Pollack– Director of the Sarcoma Program, Lurie Cancer Center of Northwestern Univ– as he discusses the latest in sarcoma therapeutics.

2

7

19

Yan Leyfman, MD

@YLeyfman

2 years

Enlightening presentation from Global Multiple Myeloma Leader, Dr. Saad Usmani, about the management of triple refractory multiple myeloma with a thorough summary of present and promising therapeutics to improve outcomes for our patients.

1

3

18

Yan Leyfman, MD

@YLeyfman

2 years

Honored to have had the opportunity to meet Dr. Patrick Hwu ( @PatrickHwuMD )-- Global Immunotherapy Leader, SITC ( @sitcancer ) President & CEO of Moffitt Cancer Center ( @MoffittNews ). Thank you for the invitation.

1

19

Yan Leyfman, MD

@YLeyfman

9 months

📣Saturday, September 2 @ 4 PM EST on @MedNewsWeek !🎙️ We are excited to be hosting Global Leader & Keynote Speaker, 🌟Dr. Kathryn Lurain🌟– Clinical Director, HIV and AIDS Malignancy Branch at the NCI– as she discusses the latest in HIV 🦠 associated cancers 🦀.

1

8

18

Yan Leyfman, MD

@YLeyfman

1 year

2

6

18

Yan Leyfman, MD

@YLeyfman

2 years

Honored to be recognized as a 2022 Hero in Healthcare by the @llmcongress . The greatest reward is making a positive difference in the lives of patients. It is humbling to be recognized by such a prestigious organization. Thank you all those who have & continue to believe in me.

Lymphoma, Leukemia & Myeloma Congress

@llmcongress

2 years

MEET YAN LEYFMAN, MD During #BloodCancerAwarenessMonth we are honoring those who have gone above and beyond their duty. For the 2nd year in a row, @YLeyfman has been nominated as a Hero in Healthcare! #LLMCONGRESS2022 #hero #hematology #hematologicmalignancies #oncology

1

4

13

10

3

18

Yan Leyfman, MD

@YLeyfman

11 months

Monday, June 19 @ 7:30 PM EST on @MedNewsWeek ! We are excited to be hosting Global Leader & Keynote Speaker, Dr. Leonard Zon– Director of the Stem Cell Program at Boston Children’s Hospital– as he discusses the latest in stem cell clonality.

2

10

18

Yan Leyfman, MD

@YLeyfman

2 years

Saturday, Nov 19 @ 4 PM EST! We are excited to be hosting Global Leader, Dr. Sanjay Reddy– Co-director, Greenberg Pancreatic Cancer Institute @ Fox Chase Cancer Center– as @MedNewsWeek 's next Keynote Speaker as he discusses the latest in pancreatic cancer therapeutics.

1

12

18

Yan Leyfman, MD

@YLeyfman

2 years

Excited to be presenting at the 2022 Scientific Wisdom Webinar on SARS-CoV-2 Variants and speak about the immunological paradigm and the latest developments in COVID-19 and COVI-Flu. Thank you to the great mentors and to the dedicated team that contributed to this project.

1

17

Yan Leyfman, MD

@YLeyfman

1 year

Monday, February 6 @ 7:30 PM EST on @MedNewsWeek ! We are excited to be hosting Global Leader & Keynote Speaker, Dr. Julie Gralow– Executive VP & Chief Medical Officer at American Society of Clinical Oncology– as she discusses ASCO’s global efforts to improve cancer care.

3

11

18

Yan Leyfman, MD

@YLeyfman

1 year

1

2

18

Yan Leyfman, MD

@YLeyfman

3 years

Very promising data from @Mesoblast showing 75% reduction in mortality at Day 60 after #Mesenchymal #StemCell #treatment in moderate-to-severe #COVID19 patients. @Mesoblast #msc #msctherapy #stemcellthrapy #stemcells

1

2

16

Yan Leyfman, MD

@YLeyfman

3 years

@almaforarizona Your heritage & culture are a part of you. Never be ashamed of it. They make you special and who you are. Your individuality makes the world better. Diversity is strength & contributed to innovation.

1

0

16

Yan Leyfman, MD

@YLeyfman

1 year

Monday, February 6 @ 7:30 PM EST on @MedNewsWeek ! We are excited to be hosting Global Leader & Keynote Speaker, Dr. Julie Gralow– Executive Vice President & Chief Medical Officer at ASCO– as she discusses ASCO’s global efforts to improve cancer care. Hope to see you there!

2

7

17

Yan Leyfman, MD

@YLeyfman

3 years

Honored to be hosting Dr. @PatrickHwuMD as our next Pioneers in Medicine speaker-- an international expert & global leader in immunotherapy-- as he discusses how to use the Immune System to Fight Cancer. Registration Link: Hope to see you there.

2

3

18

Yan Leyfman, MD

@YLeyfman

9 months

Enjoyed connecting with Dr. Jamie Von Roenn & discussing ASCO’s global education initiatives at the 2023 ASCO BT Meeting. Grateful for the engaging discussion on MedNews Week & our global education platform. Excited to stay connected! 🌍📚 #MedicalEducation #GlobalHealth

1

18

Yan Leyfman, MD

@YLeyfman

2 years

Saturday, 9/24 @ 4 PM EST We are excited to be hosting Global Leader, Dr. Moudgil– Director of Cardio-Oncology at the Cleveland Clinic– as @MedNewsWeek 's next Keynote Speaker as he discusses the latest in cardio-oncology, precision medicine & cardiology. Hope to see you there!

1

9

16

Yan Leyfman, MD

@YLeyfman

1 year

Hot off the Press in @CellPressNews ! In this study, we discuss the mechanisms behind Severe SARS-CoV-2 & place in-context the promising efficacy of extracellular vesicles as a promising, effective & efficacious therapeutic intervention for this condition.

3

8

17

Yan Leyfman, MD

@YLeyfman

11 months

A night to remember! Thank you to @MJhaveriPhD & @MusicBeatCancer for putting on an unforgettable evening filled with great music, good cheer and most importantly action to fund the next generation of biotechs & start-ups that will transform the future of cancer care.

1

4

18

Yan Leyfman, MD

@YLeyfman

3 years

Honored to have been selected to present our latest research on SARS-CoV-2 & close out Day 1 of the 2021 Cell Science Webinar Symposium in the Keynote Forum. Thank you to Drs. Park & Sharma for your great mentorship & to the dedicated team that helped with this project.

3

5

17

Yan Leyfman, MD

@YLeyfman

7 months

📣Thank you to 🌟Dr. Dana Ataya🌟– Breast Radiologist at Moffitt Cancer Center– for your riveting Keynote presentation on MedNews Week. It was a pleasure learning from you. We also want to thank 🙏 our 55,222🔥 attendees across all of our platforms.

Yan Leyfman, MD

@YLeyfman

8 months

📣Saturday, September 16 @ 4 PM EST on MedNews Week! We are excited to be hosting Global Oncology Leader & Keynote Speaker, 🌟Dr. Dana Ataya🌟– Breast Radiologist at Moffitt Cancer Center– as she discusses breast cancer and imaging biomarkers. Hope to see you there!

1

4

10

2

7

17

Yan Leyfman, MD

@YLeyfman

3 years

Elated to speak at the American Association for Precision Medicine Annual Meeting & excited to discuss our #SARS_CoV_2 & #COVIFlu models along with promising therapeutic interventions. My talk will be January 8, 2021 @ 11:15 AM PST. Conference Link:

4

1

17

Yan Leyfman, MD

@YLeyfman

4 years

@VivekSubbiah

1

4

16

Yan Leyfman, MD

@YLeyfman

7 months

🌟 Captivating presentation by Global Oncology Leader, Dr. Krishna Komanduri of UCSF, providing a thorough historical perspective for the approval of CAR T Cell Therapies, summary of present landscape, and the future of the field. 📊🔬

1

3

17

Yan Leyfman, MD

@YLeyfman

2 years

Two babies have received the first-ever gene therapy for Tay-Sachs disease after over 14 years of development

2

3

16

Yan Leyfman, MD

@YLeyfman

10 months

🌟Saturday, July 15 @ 4 PM EST on @MedNewsWeek !🌟 We are excited to be hosting Global Leader & Keynote Speaker, Dr. Jasmine Zain– Director, T-Cell Lymphoma Program at City of Hope Comprehensive Cancer Center– as she discusses the latest in T cell lymphomas.

1

5

17

Yan Leyfman, MD

@YLeyfman

2 years

Sunday, 12/5 @ 12:00 PM EST! Excited to discuss the latest developments in breast cancer with this ALL-STAR panel of global leaders— Drs. Stephanie Graff, Margaret Gatt-Mays, Stephanie Bernik, Kristin Byrne, Chirag Shah & Jose Bazan— with co-host Amit Goldman on @medtechclub .

1

5

16

Yan Leyfman, MD

@YLeyfman

2 years

Thank you to @nshss for inviting me to do a LIVE workshop about the latest developments in COVID-19, COVI-Flu & Cancer. It was a pleasure to speak to and interact with the several hundred scholars who came from all over the country.

2

3

16

Yan Leyfman, MD

@YLeyfman

10 months

Researchers at @MDAndersonNews led by Dr. Katy Rezvani ( @lab_rezvani ) show that engineered NK CARs can overcome tumor resistance when engineered with IL-15 activity. @may_daher @HindRafei

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by...

Loss of metabolic fitness is a mechanism of resistance after CAR-NK cell therapy that could be overcome by IL-15.

www.science.org

1

16

Yan Leyfman, MD

@YLeyfman

9 months

Inspirational presentation from Global NK CAR Pioneer Dr. Katy Rezvani of MD Anderson discussing the therapeutic outcomes of NK CARs and clinical trials in progress to redefine cancer care at ASCO Breakthrough 2023. #inspired #innovation

1

3

16